Malaysia Market Research
Indonesia
Market overview: The halal pharmaceutical market in Indonesia is a rapidly growing industry due to the country’s large Muslim population and the government’s efforts to promote the development of the sector, setting a target for the halal pharmaceutical industry to contribute 10% of the country’s total pharmaceutical market by 2024. This has led to increased investment in the industry, with companies expanding their halal-certified product offerings and building new production facilities to meet the growing demand for halal pharmaceuticals in Indonesia.
Local companies such as Etana, Kimia Farma, Pharos Indonesia, and Darya-Varia Laboratoria are among the leading halal pharmaceutical manufacturers in Indonesia. International pharmaceutical companies such as Abbott Laboratories have also entered the halal pharmaceutical market in Indonesia by obtaining halal certification for some of their products.
Regulations: By 2026, all products that are imported, distributed and traded in Indonesia must be certified halal, unless they are non-halal products. Non-halal products must be accompanied by the information that they are ‘non-halal’. In addition, the government is requiring pharmaceutical products to be certified halal by 2029 for over-the counter drugs and by 2034 for prescription medicine.
Market Size: Indonesia has a population of 277 million of which 87% are Muslim.
Market Potential: The Indonesian total Pharmaceuticals Muslim Consumer Market Size hit $5.4 Bn in 2021.
Market Activity: The halal pharmaceutical market in Indonesia is very active, with companies investing in research and development, production, distribution, and marketing of halal-certified pharmaceutical products. Companies are also expanding their product lines to include more halal-certified drugs, investing in new halal production facilities, and improving their manufacturing processes to meet the growing demand.
Important Activities in the Indonesian Halal Pharmaceutical Market:
VP Tries to Lure Shanghai Businesses into Indonesia’s $135b Halal Industry
Vice President Ma’ruf Amin meets Shanghai Mayor Gong Zheng in Shanghai, China, on September 19, 2023.
Indonesia’s BPJH grants Halal Certification for the COVID-19 Vaccines: Sinovac, Zifivax, Merah Putih Vaccine, and Indovac
Sinovac was the First Covid-19 Vaccine to be Halal-Certified by BPJH in April 2021 followed by Zifivax, Merah Putih Vaccine, and Indovac.
Walvax and Abogen Granted Indonesian Emergency Use Authorization for the SARS-CoV-2 mRNA Vaccine (AWcorna)
The vaccine has obtained halal certification and can be used either as a primary or booster dose.
BPOM Assures All Domestically Made COVID Vaccines are Halal
The Head of the National Agency of Drug and Food Control (BPOM), Penny K. Lukito, has announced that all three Indonesian manufacturers of COVID-19 vaccines have obtained halal certificates from the relevant authority.
Innovent and Etana Jointly Announce the Approval of Bevagen® (Bevacizumab Biosimilar)
The joint venture announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen®, a recombinant humanized anti-VEGF monoclonal antibody drug.
South Korea’s Pharma Sector Probes Halal Market with Indonesian Partners
CKD OTTO Pharmaceuticals a Korean/ Indonesian joint venture has established a halal-certified plant for producing anti-cancer drugs, and became the first oncology manufacturer in Indonesia to obtain halal certification
South Korea’s Daewoong Pharmaceutical will Collaborate with Indonesia’s National Institute of Health and Technology Development (NIHRD) on the development of COVID-19 treatments
The partnership aims to accelerate the development of effective COVID-19 treatments to help combat the pandemic.
Bio Farma has been playing a crucial Role in Indonesia’s Vaccination Efforts
Indonesian state-owned pharmaceutical company Bio Farma has been producing the CoronaVac COVID-19 vaccine under a license from Sinovac Biotech.
Daewoong Infion Achieved Halal Certification for their Diabetic Foot Ulcer Drug, Easyef
Daewoong Infion obtained marketing authorization from the Indonesian National Agency of Drug and Food Control (BPOM) and successfully obtained Halal certification in just 2 months.
Sungwoon Pharmacopia & Kimia Farma Seek Halal Certification for Nine Active Pharmaceutical Ingredients
South Korea’s Sungwoon Pharmacopia, through a joint venture with Indonesia’s PT Kimia Farma Tbk, is seeking halal certification for nine active pharmaceutical ingredients (APIs).
Daewoong Infion: Epodion Halal Certified, First Animal Cell Biopharma
Daewoong Infion is leadind leading the Indonesian erythropoietin product, and aims to enter the Middle East drug market using halal certification from Indonesia, the largest Muslim country.
Bio Farma Looks to Develop Halal MR Vaccine
Indonesia’s state-owned PT Bio Farma is planning to develop a halal measles-rubella (MR) vaccine.
